TNGX position history
The shares of Tango Therapeutics (TNGX) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 300,000 shares, $3.9M, 0.02% of portfolio
- 2021 Q4: 300,000 shares, $3.3M, 0.02% of portfolio
- 2022 Q1: 300,000 shares, $2.3M, 0.01% of portfolio
- 2022 Q2: 300,000 shares, $1.4M, <0.01% of portfolio
- 2022 Q3: 300,000 shares, $1.1M, <0.01% of portfolio
- 2022 Q4: 270,000 shares, $2M, 0.01% of portfolio, Reduce −10.0%
- 2023 Q1: not held, Exit
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: 4,000,000 shares, $12M, 0.06% of portfolio, New
- 2025 Q1: 4,610,930 shares, $6.3M, 0.04% of portfolio, Add +15.3%
- 2025 Q2: 9,157,000 shares, $47M, 0.20% of portfolio, Add +98.6%
- 2025 Q3: 21,514,000 shares, $181M, 0.74% of portfolio, Add +134.9%
- 2025 Q4: 13,061,411 shares, $116M, 0.55% of portfolio, Reduce −39.3%
- 2026 Q1: 9,097,411 shares, $190M, 1.1% of portfolio, Reduce −30.3%
- 2026 Q2: 12,277,000 shares, $384M, 1.8% of portfolio, Add +35.0%
- 2026 Q3: 4,550,688 shares, $114M, 0.49% of portfolio, Reduce −62.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|